Stuart A. Arbuckle - May 2, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
May 2, 2022
Transactions value $
-$80,778
Form type
4
Date filed
5/4/2022, 05:21 PM
Previous filing
Feb 28, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$80.8K -306 -0.47% $263.98 64.8K May 2, 2022 Direct F1
holding VRTX Common Stock 140 May 2, 2022 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.